MCCRACKEN EDWARD R 4
4 · TULARIK INC · Filed Aug 17, 2004
Insider Transaction Report
Form 4
TULARIK INCTLRK
MCCRACKEN EDWARD R
Director
Transactions
- Disposition to Issuer
Common Stock
2004-08-13−70,512→ 0 total - Disposition to Issuer
Stock Option (right to buy)
2004-08-13−10,000→ 0 totalExercise: $14.40Exp: 2012-04-17→ Common Stock (10,000 underlying) - Disposition to Issuer
Stock Option (right to buy)
2004-08-13−8,000→ 0 totalExercise: $25.38Exp: 2010-04-26→ Common Stock (8,000 underlying)
Footnotes (4)
- [F1]Disposed of pursuant to merger agreement between issuer and Amgen Inc. in exchange for 31,800 shares of Amgen common stock having a market value of $55.432 per share pursuant to the terms of the merger agreement.
- [F2]This option, which provided for vesting in equal annual installments over a four-year period until full vest on April 26, 2004, was assumed by Amgen, Inc. in the merger and replaced with an option to purchase 3,608 shares of Amgen common stock for $56.27 per share.
- [F3]This option, which provided for vesting in equal annual installments over a four-year period until full vest on April 24, 2005, was assumed by Amgen, Inc. in the merger and replaced with an option to purchase 3,608 shares of Amgen common stock for $46.41 per share.
- [F4]This option, which provided for vesting in equal annual installments over a four-year period until full vest on April 18 2006, was assumed by Amgen, Inc. in the merger and replaced with an option to purchase 4,510 shares of Amgen common stock for $31.93 per share.